PHVS

31.19

0.58% 0.18

Dopo l'orario di chiusura: 31.19

Pharvaris Nv (PHVS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$31.01

Aprire:

$31.21

Volume 24 ore:

591.38K

Relative Volume:

0.80

Capitalizzazione di mercato:

$2.19B

Reddito:

Utile/perdita netta:

$-195.21M

Rapporto P/E:

-9.8196

EPS:

-3.1763

Flusso di cassa netto:

$-176.19M

1 W Prestazione:

-2.59%

1M Prestazione:

-11.32%

6M Prestazione:

+9.21%

1 anno Prestazione:

+34.56%

Intervallo 1D:

$30.69

$31.55

Intervallo di 1 settimana:

$30.69

$32.46

Portata 52W:

$20.65

$43.25

Pharvaris Nv Stock (PHVS) Company Profile

Nome

Pharvaris Nv

Settore

Healthcare (1064)

Industria

Biotechnology (595)

Telefono

Indirizzo

Dipendente

129

Cinguettio

Prossima data di guadagno

2026-11-11

Ultimi documenti SEC

PHVS's Discussions on Twitter

Compare PHVS vs VRTX, MRNA, REGN, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PHVS Pharvaris Nv	31.19	2.25B	0	-195.21M	-176.19M	-3.1763
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-09	Iniziato	Wolfe Research	Outperform
2026-03-09	Iniziato	RBC Capital Mkts	Outperform
2025-10-15	Iniziato	H.C. Wainwright	Buy
2025-10-09	Aggiornamento	BofA Securities	Underperform → Neutral
2025-06-11	Iniziato	Guggenheim	Buy
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2023-09-25	Iniziato	Wedbush	Outperform
2023-08-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-10-05	Iniziato	Bryan Garnier	Buy
2022-09-13	Ripresa	JMP Securities	Mkt Outperform
2022-08-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-22	Downgrade	BofA Securities	Neutral → Underperform
2022-05-25	Iniziato	JMP Securities	Mkt Outperform
2021-03-02	Iniziato	BofA Securities	Neutral
2021-03-02	Iniziato	Morgan Stanley	Overweight
2021-03-02	Iniziato	Oppenheimer	Outperform
2021-03-02	Iniziato	SVB Leerink	Outperform

Mostra tutto

Pharvaris Nv Borsa (PHVS) Ultime notizie

Sep 26, 2026

Form 144 PHARVARIS N.V. For: 26 September By Investing.com - Investing.com Australia

Sep 26, 2026

Form 4 Pharvaris N.V. For: 26 September By Investing.com - Investing.com Nigeria

Sep 26, 2026

Form 4 Pharvaris N.V. For: 26 September - Investing.com India

Sep 26, 2026

Sep 25, 2026

Trade Alert: Independent & Non-Executive Vice Chairman Of Pharvaris Hans J. G. C. Schikan Has Sold Stock - webull.com

Sep 25, 2026

Sep 23, 2026

A Pharvaris (PHVS) director proposes selling shares valued at $395,524. - Stock Titan

Sep 23, 2026

Form 4 Pharvaris N.V. For: 23 September - Investing.com India

Sep 23, 2026

Form 4 Pharvaris N.V. For: 23 September By Investing.com - Investing.com Nigeria

Sep 23, 2026

Sep 22, 2026

(PHVS) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Sep 22, 2026

Planned $7M Pharvaris (NASDAQ: PHVS) stock sale disclosed for founder shares - Stock Titan

Sep 22, 2026

After $7M stock sale, Pharvaris (NASDAQ: PHVS) director plans more - Stock Titan

Sep 22, 2026

Wall Street Analysts Believe Pharvaris (PHVS) Could Rally 36.16%: Here's is How to Trade - Eastern Progress

Sep 22, 2026

Pharvaris (NASDAQ: PHVS) officer plans Rule 144 sale of 6,000 shares - Stock Titan

Sep 21, 2026

Pharvaris (PHVS) CEO buys 300,000 shares in rights exercise - Stock Titan

Sep 21, 2026

Pharvaris Chief Early Development Anne Lesage disposes of USD 765,466 in common shares - Bitget

Sep 21, 2026

Sep 20, 2026